Cell Impact (FRA:ICL) Cyclically Adjusted Revenue per Share: €0.07 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cell Impact Cyclically Adjusted Revenue per Share?

Cell Impact FRA:ICL +350.00% Cyclically Adjusted Revenue per Share is €0.07 as of Mar. 2026. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cell Impact's adjusted revenue per share for the three months ended in Mar. 2026 was €0.001. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.07 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cell Impact's average Cyclically Adjusted Revenue Growth Rate was -1.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cell Impact was 27.00% per year. The lowest was 0.80% per year. And the median was 12.30% per year.

As of today (2026-07-19), Cell Impact's current stock price is €0.0099. Cell Impact's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €0.07. Cell Impact's Cyclically Adjusted PS Ratio of today is 0.14.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cell Impact was 219.27. The lowest was 0.08. And the median was 3.47.


Cell Impact  (FRA:ICL) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cell Impact's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.0099/0.07
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cell Impact was 219.27. The lowest was 0.08. And the median was 3.47.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cell Impact Cyclically Adjusted Revenue per Share Related Terms


Cell Impact Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Cell Impact's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Impact Cyclically Adjusted Revenue per Share Chart

Cell Impact Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.19 0.11 0.12 0.12

Cell Impact Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.30 0.07 0.12 0.07

FRA:ICL vs CRS, ATI, MLI: Cyclically Adjusted Revenue per Share Comparison

For the Metal Fabrication subindustry, Cell Impact's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Impact Cyclically Adjusted PS Ratio vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Cell Impact's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cell Impact's Cyclically Adjusted PS Ratio falls into.



Cell Impact Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cell Impact's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.001/133.5600*133.5600
=0.001

Current CPI (Mar. 2026) = 133.5600.

Cell Impact Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.009 101.019 0.012
201609 0.002 101.138 0.003
201612 0.004 102.022 0.005
201703 0.012 102.022 0.016
201706 0.001 102.752 0.001
201709 0.001 103.279 0.001
201712 -0.004 103.793 -0.005
201803 0.006 103.962 0.008
201806 0.003 104.875 0.004
201809 0.018 105.679 0.023
201812 0.013 105.912 0.016
201903 0.013 105.886 0.016
201906 0.021 106.742 0.026
201909 0.011 107.214 0.014
201912 0.006 107.766 0.007
202003 0.021 106.563 0.026
202006 0.015 107.498 0.019
202009 0.023 107.635 0.029
202012 0.038 108.296 0.047
202103 0.030 108.360 0.037
202106 0.054 108.928 0.066
202109 0.071 110.338 0.086
202112 0.047 112.486 0.056
202203 0.042 114.825 0.049
202206 0.039 118.384 0.044
202209 0.032 122.296 0.035
202212 0.032 126.365 0.034
202303 0.036 127.042 0.038
202306 0.030 129.407 0.031
202309 0.016 130.224 0.016
202312 0.002 131.912 0.002
202403 0.004 132.205 0.004
202406 0.017 132.716 0.017
202409 0.004 132.304 0.004
202412 0.001 132.987 0.001
202503 0.000 132.825 0.000
202506 0.001 133.699 0.001
202509 0.000 133.480 0.000
202512 0.000 133.390 0.000
202603 0.001 133.560 0.001

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €0.07 mean?
Cell Impact (FRA:ICL) has a Cyclically Adjusted Revenue per Share of €0.07 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cell Impact and its competitors.
Is Cell Impact's Cyclically Adjusted Revenue per Share too high?
Cell Impact's current Cyclically Adjusted Revenue per Share is €0.07.
How does Cell Impact's Cyclically Adjusted Revenue per Share compare to CRS and ATI?
Cell Impact's Cyclically Adjusted Revenue per Share of €0.07 can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Industrial Products company?
A good Cyclically Adjusted Revenue per Share depends on the Industrial Products industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cell Impact and its competitors. Cell Impact's current Cyclically Adjusted Revenue per Share is €0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (FRA:ICL) is currently considered Fairly Valued. The stock's GF Value™ is €0.01, compared to a current price of €0.01 — trading 1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €0.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Cell Impact (FRA:ICL), the current Cyclically Adjusted Revenue per Share is €0.07 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cell Impact Business Description

Other Exchanges CI:Sweden
Address Kallmossvagen 7A, Karlskoga, SWE, 691 52
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.